SUPERSEDED Local Coverage Determination (LCD)

Coronary Computed Tomography Angiography (CCTA)

L35121

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.
Superseded
To see the currently-in-effect version of this document, go to the section.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L35121
Original ICD-9 LCD ID
Not Applicable
LCD Title
Coronary Computed Tomography Angiography (CCTA)
Proposed LCD in Comment Period
N/A
Source Proposed LCD
DL35121
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 10/28/2021
Revision Ending Date
11/29/2023
Retirement Date
N/A
Notice Period Start Date
N/A
Notice Period End Date
N/A

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description
Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

Italicized font represents CMS national language/wording copied directly from CMS Manuals or CMS Transmittals. Contractors are prohibited from changing national language/wording.

Title XVIII of the Social Security Act (SSA):

Section 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.

Section 1862(a)(1)(A) excludes expenses incurred for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Section 1862 (a)(7) excludes routine physical examinations.

Code of Federal Regulations: 42 CFR Section 410.32 – Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostics tests: Conditions.  This indicates that diagnostic tests may only be ordered by the treating physician (or other treating practitioner acting within the scope of his or her license and Medicare requirements) who furnishes a consultation or treats a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. Tests not ordered by the physician (or other qualified non-physician provider) who is treating the beneficiary are not reasonable and necessary.

CMS Publications:

CMS Publication 100-03, National Coverage Determination Manual, Chapter 1- Coverage Determinations Part 4, §220.1 Computed Tomography (CT)

CMS Publication 100-04, Medicare Claims Processing Manual, Chapter 13 – Radiology Services and Other Diagnostic Procedures, §20 Payment Conditions for Radiology Services

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

The multi-detector helical computed tomography (MDCT) technology requires thin (up to 1 mm) slices, 0.5 to 0.75 mm reconstructions, multiple simultaneous images (e.g. 16, 32, 64 or more slices), and cardiac gating (often requiring beta blockers for ideal heart rate). There is significant post-processing, depending on the number of slices per second for image generation. For coronary artery imaging, the resulting images show a high correlation with stenotic lesions noted on diagnostic cardiac catheterization but more importantly, with atheromas on intracoronary ultrasound.

Current available body of evidence demonstrates that CCTA can reliably rule out the presence of significant coronary artery disease (CAD) in patients with a low to intermediate probability of having CAD and can reliably achieve a high degree of diagnostic accuracy and technical performance necessary to replace conventional angiography.

Indications:

  1. CCTA used as an alternative to invasive angiography and stress testing. For patients with anginal symptoms, patients with unclear stress tests results, patients in whom the stress test result contradicts the clinical assessment, to determine the patency of coronary artery bypass grafts, as an alternative when cardiac catheterization is impossible or carries a high risk, to rule out stenosis before non-coronary cardiac surgery such as valve replacement or resection of tumors and clarifying unclear finding after invasive angiography. 
  2. CCTA used to assess patients suspected of having a congenital coronary anomaly of great vessels, cardiac chambers, and valves. It is often used after an anomaly has been identified following a different test such as prior invasive coronary angiogram. CCTA is used to decide if surgery is indicated and for surgical planning. 
  3. CCTA used to evaluate acute chest pain in the emergency department (ED). The rationale is to quickly triage patients in order to rule out coronary artery disease as a possible cause of symptoms. Many will present with a normal electrocardiogram and myocardial enzymes. 
  4. CCTA used to assess coronary or pulmonary venous anatomy. Coronary mapping is primarily for pre-surgical planning such as pacemaker lead placement in the lateral coronary vein to resynchronize cardiac contraction in patients with heart failure or guiding biventricular pacemaker placement. Pulmonary vein anatomy can vary from patient to patient. Pulmonary vein mapping is primarily for catheter ablation which can isolate electrical activity from the pulmonary veins and allow for the elimination of recurrent atrial fibrillation or help eliminate procedural complications.
  5. CCTA used to assess etiology with new onset heart failure for evaluation of coronary arteries.

 Limitations:

  1. The test is never covered for screening, i.e., in the absence of signs, symptoms or disease. 
  2. The test will be considered not medically necessary if the anticipated results are not expected to provide new, additional information to that already previously obtained from other tests (such as stress myocardial perfusion images or cardiac ultrasound). New or additional information should facilitate the management decision, not merely add a new layer of testing. 
  3. The test will be considered not medically necessary if pretest evaluation indicates that the patient would require invasive cardiac angiography for further diagnosis or for therapeutic intervention. 
  4. The test may be denied, on post-pay review, as not medically necessary when used for cardiac evaluation if there were pre-test knowledge of sufficiently extensive calcification of the suspect coronary segment that would diminish the interpretive value. (e.g., angina decubitus, unstable angina, Prinzmetal angina, etc.) 
  5. Coverage is limited to devices that process thin, high-resolution slices (1mm or less). The multi-detector scanners must have at least 64 slices per rotation capability. 
  6. The administration of beta blockers and the monitoring of the patient during MDCT/CCTA by a physician experienced in the use of cardiovascular drugs is included as part of the test and is not a separately payable service. 
  7. All studies must be ordered by the physician/qualified non-physician practitioner treating the
    patient and who will use the results of the test in the management of the patient. 
  8. The test must be performed under the direct supervision of a physician, similar to the stress myocardial perfusion imaging. 
  9. This LCD does not address electron beam tomography (EBT) technology or Ultrafast CT for coronary artery examination. There is no extension of coverage of EBT based on this policy. 
  10. Quantitative calcium scoring is not a covered service and will be denied as not medically necessary. Calcium scoring reported in isolation is considered a screening service. When performed in association with CT angiography, there is neither separate nor additional included reimbursement for the calcium scoring.
  11. Atrial fibrillation or atrial flutter alone is not an indication; atrial fibrillation or atrial flutter with planned ablation therapy is allowed.
Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
View Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information

The frequency of the exam must be reasonable and justified by the course of the patient’s illness.

Sources of Information
N/A
Bibliography

Abbara S, Arbab-Zadeh A, Callister TQ, et al. SCCT guidelines for performance of coronary computed tomographic angiography: A report of the society of cardiovascular computed tomography guidelines committee. Journal of Cardiovascular Computed Tomography. 2009;3(3):190-204. doi:10.1016/j.jcct.2009.03.004

Achenbach S. Top ten clinical indications for coronary CT angiography. https://appliedradiology.com/articles/top-ten-clinical-indications-for-coronary-ct-angiography. Published 2008. Accessed October 4, 2021.

Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. New England Journal of Medicine. 2015;372(14):1291-1300. doi:10.1056/nejmoa1415516

Erol C, Seker M. The prevalence of coronary artery variations on coronary computed tomography angiography. Acta Radiologica. 2012;53(3):278-284. doi:10.1258/ar.2011.110394

Gueret P, Deux J-F, Bonello L, et al. Diagnostic performance of computed tomography coronary angiography (from the prospective National Multicenter Multivendor EVASCAN study). The American Journal of Cardiology. 2013;111(4):471-478. doi:10.1016/j.amjcard.2012.10.029

Rajani R, Brum RL, Preston R, Carr-White G, Berman DS. Coronary computed tomography angiography for the evaluation of patients with acute chest pain. International Journal of Clinical Practice. 2011;65(12):1267-1273. doi:10.1111/j.1742-1241.2011.02788.x

Soon K, Wong C. Coronary computed tomography angiography: A new wave of cardiac imaging. Internal Medicine Journal. 2012;42:22-29. doi:10.1111/j.1445-5994.2012.02901.x

Taylor AJ, Cerqueira M, Hodgson JMB, et al. ACCF/SCCT/ACR/aha/ase/ASNC/nasci/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. Journal of the American College of Cardiology. 2010;56(22):1864-1894. doi:10.1016/j.jacc.2010.07.005

Tresoldi S, Mezzanzanica M, Campari A, Salerno Uriarte D, Cornalba G. The role of computed tomography coronary angiography in the management of coronary anomalies. Journal of Cardiac Surgery. 2012;28(1):33-36. doi:10.1111/jocs.12040

Van Werkhoven JM, Gaemperli O, Schuijf JD, et al. Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood. Heart. 2009;95(19):1607-1611. doi:10.1136/hrt.2009.167353

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
10/28/2021 R12

10/28/2021 Sources of information updated to AMA format and moved under Bibliography. Review completed 09/30/2021.

  • Other (Review)
08/27/2020 R11

08/27/2020 Review completed 08/05/2020 with no change in coverage.

  • Other (Review)
11/28/2019 R10

Change Request 10901 Local Coverage Determinations (LCDs): it will no longer be appropriate to include Current Procedure Terminology (CPT)/Health Care Procedure Coding System (HCPCS) codes or International Classification of Diseases Tenth Revision-Clinical Modification (ICD-10-CM) codes in the LCDs. All CPT/HCPCS, ICD-10 codes, and Billing and Coding Guidelines have been removed from this LCD and placed in the Billing and Coding Article related to this LCD. Consistent with Change Request 10901, if any language from IOMs and/or regulations was present in the LCD, it has been removed and the applicable manual/regulation has been referenced.

  • Revisions Due To Code Removal
10/01/2019 R9

09/26/2019 ICD-010 code update: Added I48.11, I48.19, I48.20, and I48.21 to Group 1. Removed deleted codes I48.1, I48.2 from Group 1.

  • Revisions Due To ICD-10-CM Code Changes
09/01/2018 R8

09/01/2018 Annual review done 08/02/2018.

  • Other (Annual Review)
06/01/2018 R7

06/01/2018 Formatting changes made. For clarification, removed the non-covered code 75571 from CPT/HCPCS Codes Group 1 and created Group 2 Non-covered codes as supported by the verbiage in the Limitations section.  No change in coverage.

  • Other
10/01/2017 R6

10/01/2017 Per ICD-10 code updates: In Group 1: added codes I50.810, I50.811, I50.812, I50.813, I50.814, I50.82, I50.83, I50.84, I50.89, and R06.03.

  • Revisions Due To ICD-10-CM Code Changes
09/01/2017 R5

09/01/2017 Annual review done 08/02/2017. No change in coverage. Grammatical corrections made. At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Annual Review)
10/01/2016 R4 10/01/2016 Per ICD-10 Code Updates: In Group 1: deleted codes Q25.2 and Q25.4 and added codes Q25.21, Q25.29, Q25.40, Q25.41, Q25.42, Q25.43, Q25.44, Q25.45, Q25.46, Q25.47, Q25.48, and Q25.49, effective 10/01/2016.
  • Revisions Due To ICD-10-CM Code Changes
09/01/2016 R3 09/01/2016 Annual review done 08/02/2016. Removed CAC information. No change in coverage.
  • Other ((Annual review))
10/01/2015 R2 09/01/2015 Annual review done 08/06/2015. Updated Source of Information. No change in coverage.
  • Other (Annual review)
10/01/2015 R1 09/10/2014: Removed hyperlink in Sources of Information.
  • Other
N/A

Associated Documents

Attachments
N/A
Related National Coverage Documents
N/A
Public Versions
Updated On Effective Dates Status
11/20/2023 11/30/2023 - N/A Currently in Effect View
10/19/2021 10/28/2021 - 11/29/2023 Superseded You are here
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer